Resolution of Precapillary Pulmonary Hypertension After Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Systematic Review and Case Report
- PMID: 34974893
- DOI: 10.1016/j.transproceed.2021.11.010
Resolution of Precapillary Pulmonary Hypertension After Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Systematic Review and Case Report
Abstract
Background: Pulmonary hypertension (PH) is a known complication of hereditary hemorrhagic telangiectasia (HHT) in patients with hepatic arteriovenous malformations (HAVM). Orthotopic liver transplantation (OLT) is a recognized treatment of HAVM in HHT, but its effect on PH has not been reported in detail before.
Methods: Systematic review on HHT patients with pre- or postcapillary PH who underwent OLT and report of a case.
Results: Twenty-one patients were included from 7 articles, all case reports or case series. All had high-output cardiac failure prior to OLT. Two patients had precapillary PH, both related to ALK1 mutations. All patients but 1 showed significant improvement or complete resolution of PH after transplantation. One patient died of acute cardiac failure postoperatively. We also report the case of a 72-year-old woman with type 3 HHT and severe mixed pre- and postcapillary PH. The patient presented with multiple HAVM, left-to-right shunting, and severe but partially reversible combined pre- and postcapillary PH, without ALK1 mutation. After recurrent cholangitis episodes, liver abscesses, and severe obstruction of the right-sided biliary tree, an interdisciplinary decision was taken to proceed with OLT despite PH. Intraoperatively, PH resolved almost instantly after hepatic artery ligation and hepatectomy.
Conclusions: In our patient, OLT completely abrogated mixed pre- and postcapillary PH. Based on this systematic review, we suggest that OLT should be considered a viable treatment option in patients with HHT, HAVM, and mixed pre- and postcapillary PH, featuring cardiac failure and drug responsive PH, rather than being seen as a major risk factor for cardiopulmonary complications.
Copyright © 2021 Elsevier Inc. All rights reserved.
Similar articles
-
Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.Liver Transpl. 2010 Mar;16(3):340-7. doi: 10.1002/lt.21990. Liver Transpl. 2010. PMID: 20209594
-
Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.Ann Surg. 2006 Dec;244(6):854-62; discussion 862-4. doi: 10.1097/01.sla.0000247258.35406.a4. Ann Surg. 2006. PMID: 17122610 Free PMC article.
-
Pulmonary vascular manifestations of hereditary hemorrhagic telangiectasia (rendu-osler disease).Respiration. 2007;74(4):361-78. doi: 10.1159/000103205. Respiration. 2007. PMID: 17641482 Review.
-
High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment.Orphanet J Rare Dis. 2020 Nov 26;15(1):334. doi: 10.1186/s13023-020-01583-6. Orphanet J Rare Dis. 2020. PMID: 33243256 Free PMC article.
-
The role of liver transplantation in the treatment of hereditary hemorrhagic telangiectasia: a short literature review.Transplant Proc. 2007 Jul-Aug;39(6):2045-7. doi: 10.1016/j.transproceed.2007.05.022. Transplant Proc. 2007. PMID: 17692689 Review.
Cited by
-
Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.J Clin Med. 2022 Sep 24;11(19):5624. doi: 10.3390/jcm11195624. J Clin Med. 2022. PMID: 36233492 Free PMC article. Review.
-
Pulmonary hypertension in hereditary hemorrhagic telangiectasia: A clinical review.Pulm Circ. 2023 Oct 19;13(4):e12301. doi: 10.1002/pul2.12301. eCollection 2023 Oct. Pulm Circ. 2023. PMID: 37868718 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical